Microsoft word - docs-#85204-v1-ebc_-_emergency_evaluation_of_suspected_str…
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Emergency Evaluation of Suspected Stroke NIH STROKE SCALE ________ 1A Level of Consciousness –Is the patient alert, drowsy,ect
Document time of onset of symptoms (if known), or the last
time the patient was known to be at previous baseline or
________ 1B LOC Questions –Ask patient the month and their age ________ 1C LOC commands –Ask patient to open/close eyes and then
NIH Stroke Scale Score: _________________
________ 2 Best Gaze-Only horizontal movement tested. Oculocephalic
reflex is OK, but not calorics. Eyes open patient follows finger
• Record weight in kg: __________________
0= normal 1= partial gaze palsy 2= forced deviation
• CT head now. Notify Radiology of suspected stroke.
________ 3 Visual –Test by confrontation. Introduce visual stimulus to
Radiologist to notify ordering physician of CT results
patient’s upper an lower field quadrants
2= complete hemianopia 3= bilateral hemianopia
________ 4 Facial Palsy-Ask patient to show teeth/smile, raise eyebrows
• STAT Complete Blood Cell Count with differential.
________ 5A&B Motor Arm -Extend arm, palm down, to 90 degrees if
Other: _____________________________________
________ 6A&B Motor-Leg-Elevate leg to 30 degrees and flex at hip always
Other: _____________________________________
• Initiate and maintain saline lock if no other IV access.
• Normal Saline at ___________________ (specify rate), or
________ 7. Limb Ataxia –Finger-nose, heel-shin tests done on both
Other IV fluid: ________________________________
Blood Pressure treatment and parameters:
________ 8 Sensory Use a pinprick to face, arm, trunk and leg-compare
For patients receiving t-PA: Alteplase (Activase) see
side to side. Assess patient’s awareness of being touched.
Labetalol orders on page 2 of 3 of this order set.
For patients who are NOT candidates for t-PA: Alteplase
________ 9 Best Language-Ask patient t name items, describe a picture,
(Activase), AHA Guidelines for the Early Management of
read a sentence; intubated patients should write responses. Adults with Ischemic Stroke (May 2007) recommends that
0= No aphasia 1= Mild to moderate aphasia
medications should be withheld unless the systolic blood
pressure is >220 mm Hg or the diastolic blood pressure is
________ 10 Dysarthria-Evaluate speech clarity by asking patient to repeat
0= Normal Articulation 1= Mild to moderate dysarthria
2= Near to unintelligible UN= Intubated or other barrier
________ 11 Extinction and Inattention-Use information from prior testing to
____________________________________________
identify neglect or double simultaneous stimuli testing.
0= No neglect 1= Partial neglect 2=Complete neglect
_______________ (Date)____________(Time)
______ NIHSS Total Score
S:\Evidence Based Care\EBC Order Development\FY2008 Orders\Stroke\Word Processing Versions\DOCS-#85204-v1-EBC_-_Emergency_Evaluation_of_Suspected_Stroke_-_Alegent_Health_Administration_-_AH_(METRO).DOC 11/5/2007
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Emergency Evaluation of Suspected Stroke INCLUSION Criteria for t-PA: Alteplase (Activase)
Clinical diagnosis of ischemic stroke causing a
Patient DOES NOT MEET criteria for t-PA: Alteplase
Base line CT scan showing no evidence of
• STOP: Refer to Acute Stroke Management order set (Doc #85510).
Time of symptom onset well established to be less
than 180 minutes before treatment would begin.
Patient is a candidate for t-PA: Alteplase (Activase).
Patient and/or family aware of the risk of
• Emergency Department patient to remain in the
hemorrhage (1 in 16) and potential benefit (30%
Emergency Department until t-PA: Alteplase
greater chance of improvement to No or Minimal
Disability at 3 months compared with those that did
• Transfer in hospital non-ICU patient to ICU as soon as
not receive t-PA: Alteplase (Activase) therapy).
EXCLUSION Criteria for t-PA: Alteplase (Activase) Administer t-PA: Alteplase (Activase) Contraindications / (Absolute/Relative)
Evidence of intracranial hemorrhage on pretreatment
Alteplase (Activase) 0.09 mg/kg IV once for 1 minute
Clinical presentation suggestive of subarachnoid
• Alteplase (Activase) 0.81 mg/kg IV once for 59 minute
maintenance dose. Maximum dose 81 mg. Refer to
CT shows multilobar infarction (hypodensity greater
dosing table on page 3 of 3 for reference.
• Perform neuro checks and measure blood pressure
every 15 minutes during the infusion and for 2 hours
History of aneurysm or AVM or neoplasm.
Acute bleeding diathesis including but not limited to:
If the patient develops severe headache, acute
- received heparin within 48 hours and has an
hypertension, nausea, or vomiting, discontinue the t-
PA: Alteplase (Activase) infusion, notify the physician,
- currently on oral anticoagulants or recent use with an
elevated prothrombin time >15 seconds or INR >1.7
• Whenever possible, avoid the placement of
Uncontrolled hypertension: At the time treatment
nasogastric tubes, indwelling bladder catheters, or
systolic BP > 185 mmHg or diastolic BP > 110 mmHg
intra-arterial pressure catheters for 24 hours after
t-PA: Alteplase (Activase) infusion end time.
Active internal bleeding or acute trauma.
• No anticoagulants or antiplatelet agents (including,
Arterial puncture at a non-compressible site in the
but not limited to: warfarin, aspirin, plavix, lovenox or
heparin) within 24 hours of t-PA: Alteplase
Intracranial, intraspinal surgery or serious head
Pregnancy, lactation, or parturition within the previous
Labetalol 20 mg IV over 2 minutes for systolic blood
pressure > 185 mm Hg or diastolic blood pressure
Relative Contraindications
• If systolic BP remains > 185 mm Hg or diastolic BP
Only minor (NIHSS <3) or rapidly improving stroke
remains > 110 mm Hg for 10 minutes after first
Labetalol dose, then administer Labetalol 40 mg IV
Major surgery or other serious trauma during
• Refer to Acute Stroke Post t-PA: Alteplase (Activase)
order set (Doc #85511) for further orders.
Recent acute MI or pericarditis within 3 months.
Post myocardial infarction pericarditis Abnormal blood glucose <50 or >400mg/dl.
____________________________________________
CT scan shows evidence of large middle cerebral
artery territory infarct: edema, mass effect, and
_______________ (Date)____________(Time)
obliteration of sulci in more than 1/3 of middle
S:\Evidence Based Care\EBC Order Development\FY2008 Orders\Stroke\Word Processing Versions\DOCS-#85204-v1-EBC_-_Emergency_Evaluation_of_Suspected_Stroke_-_Alegent_Health_Administration_-_AH_(METRO).DOC 11/5/2007
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Emergency Evaluation of Suspected Stroke Dosing Table for t-PA: Alteplase (Activase): 100 mg vial to be prepared as a single stock bottle with both the loading and maintenance doses administered from this supply with unneeded volume discarded.
S:\Evidence Based Care\EBC Order Development\FY2008 Orders\Stroke\Word Processing Versions\DOCS-#85204-v1-EBC_-_Emergency_Evaluation_of_Suspected_Stroke_-_Alegent_Health_Administration_-_AH_(METRO).DOC 11/5/2007
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Acute Stroke Management Orders Admit to Inpatient
__________________________________________
Neurology: Dr. __________________________ notified
Pulmonary: Dr. __________________________ notified
Cardiology: Dr. __________________________ notified
Other: Dr. ______________________________ notified
• Refer to medication reconciliation for home medications.
• Neurocheck with vital signs per nursing unit protocol.
• Assess tobacco status. Offer cessation education to all
patients with a history of use in the past 12 months.
• Pneumoccocal & Influenza screening and vaccination per
• Oxygen and Oxygen Monitoring per RT Protocol.
• Accurate intake and output every 8 hours.
• Initiate and maintain saline lock if no other IV access.
_______________________________________
(avoid use of hypotonic or glucose-containing replacement fluids)
• Speech therapy to conduct bedside swallowing evaluation
(if not already done); Notify physician of results.
• NPO until swallowing evaluation completed.
• Speech, Physical and Occupational therapies each to
Acute Inpatient Rehab Referral (Call 572-2886)
Referral is to admission coordinator for case review and
facilitation. This is not a physician consult.
DVT / Venous Thromboembolism (VTE) Prophylaxis:
• Nursing to screen all patients 18 years or greater for
DVT/VTE Risk Factors. Place Thrombosis Prophylaxis
order (Doc #83629) on chart and document total risk score
for physician review and order modification as appropriate.
Doc # 85510 v1, continued on page 2 of 2
DOCS-#85510-v1-EBC_-_Acute_Stroke_Management_Orders_-_Alegent_Health_Administration_-_AH_(METRO).DOC
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Acute Stroke Management Orders Laboratory Orders: (specify date/time or frequency)
CBC: ________________________________________
Basic metabolic panel: ___________________________
PTT: _______________________________________
PT and INR: ___________________________________
Other: _____________________________________
Other: _____________________________________
Additional Diagnostics:
Other: _____________________________________
Evidence Based Reminders:
Other: _____________________________________
Medications: Blood Pressure Treatment in Acute Stroke
Labetalol 10 mg IV over 2 minutes for systolic blood
AHA Guidelines for the Early Management of Adults With
pressure > 220 mm Hg or diastolic blood pressure
> 120 mm Hg. May repeat every 20 minutes x 2.
It is generally agreed that patients with markedly
elevated blood pressure may have their blood pressure
lowered. A reasonable goal would be to lower blood
___________________________________________.
pressure by ~15% during the first 24 hours after onset
of stroke. The level of blood pressure that would
Warfarin (Coumadin) ___________________________
mandate such treatment is not known, but consensus
for patients with atrial fibrillation, a cardioembolic source
exists that medications should be withheld unless the
of stroke, or a mechanical prosthetic heart valve.
systolic blood pressure is >220 mm Hg or the diastolic
Platelet Inhibitors for patients who do not have an indication for Warfarin (Coumadin): Choose ONE Option.
(Class I, Level of Evidence C). This recommendation has changed from previous statements in that a potential goal
Aspirin 81 mg orally once daily, OR for lowering blood pressure is now included. (Stroke.
Aspirin 325 mg orally once daily, OR
Aggrenox 25mg/200mg, 1 capsule orally twice daily, OR
Clopidogrel (Plavix) 300 mg loading dose times one dose,
Contraindications to Statin Therapy
Pregnancy, breast feeding, active liver disease, or
unexplained persistent elevation of serum transaminases.
________________________________________ Ordering MD/DO/NP/PA signature _________________ (Date) _____________ (Time) Doc # 85510 v1
DOCS-#85510-v1-EBC_-_Acute_Stroke_Management_Orders_-_Alegent_Health_Administration_-_AH_(METRO).DOC
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Acute Stroke POST t-PA: Alteplase (Activase) Orders This order set is strictly for acute stroke patients who have received t-PA: Alteplase (Activase) infusion and should be executed immediately following the infusion. • Document end time of t-PA: Alteplase (Activase) infusion:
Date: _________________ Time: ________________
• Admit to inpatient and place patient in ICU.
• eICU Category II – Critical Care Management.
• Place Acute Stroke Management order set (Doc #85510)
on chart for physician review and completion.
______________________________________________
Neurology: Dr. __________________________
Pulmonary: Dr. __________________________ notified
Cardiology: Dr. __________________________ notified
Other: Dr. ______________________________ notified
• Perform neuro check and measure blood pressure every
15 minutes for 2 hours, then every 30 minutes for 6 hours,
• Oxygen and oxygen monitoring per RT protocol.
• Speech therapy to conduct bedside swallowing evaluation;
Notify physician of results and recommendations.
NPO until swallowing evaluation completed.
• Whenever possible, avoid the placement of nasogastric
tubes, indwelling bladder catheters, or intra-arterial
pressure catheters for 24 hours after t-PA: Alteplase
• No anticoagulants or antiplatelet agents (including, but
not limited to: warfarin, aspirin, plavix, lovenox or heparin)
within 24 hours of t-PA: Alteplase (Activase) infusion end
Doc # 85511 v1, continued on page 2 of 2
DOCS-#85511-v1-EBC_-_Acute_Stroke_POST_t-PA_Alteplase_(Activase)_Orders_-_Alegent_Health_Administration_-_AH_(METR.DOC
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Acute Stroke POST t-PA: Alteplase (Activase) Orders
• Notify physician if patient exhibits worsening of For symptomatic hemorrhage after t-PA has been neurological symptoms, new or worse headache, or given consider the following: nausea/vomiting.
→ STAT head CT, if ICH suspected → Consult Neurosurgery for ICH
→ Check CBC, PT, PTT, platelets, fibrinogen and D-
• IV fluids: ___________________________________
dimer. Repeat every 2 hours until bleeding is
(avoid use of hypotonic or glucose-containing replacement fluids)
→ Give fresh frozen plasma 2 units every 6 hours for
Labetalol 10 mg IV over 2 minutes for systolic blood
pressure > 185 mm Hg or diastolic blood pressure
→ Give cryoprecipitate 20 units. If fibrinogen level <
200 mg/dL at 1 hr, repeat cryoprecipitate dose.
• If systolic BP remains > 185 mm Hg or diastolic BP
remains > 110 mm Hg for 10 minutes after first
→ Institute frequent neurochecks and therapy of
Labetalol dose, then administer Labetalol 20 mg IV
→ May give aminocaproic acid (Amicar) 5 g in 250 cc
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________
____________________________________________ ________________________________________ Ordering MD/DO/NP/PA signature _________________ (Date) _____________ (Time) Doc # 85511 v1
DOCS-#85511-v1-EBC_-_Acute_Stroke_POST_t-PA_Alteplase_(Activase)_Orders_-_Alegent_Health_Administration_-_AH_(METR.DOC
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Acute Stroke Discharge Orders Discharge patient to:
Home with Home Health Care with the following:
PT evaluate and treat _________ x per week
OT evaluate and treat _________ x per week
ST evaluate and treat _________ x per week
SNF (must complete community wide transfer sheet)
Transfer to Acute Rehab according to previously
established plan (evaluation and acceptance).
PT evaluate and treat 3 times per week for 4 weeks
OT evaluate and treat 3 times per week for 4 weeks
ST evaluate and treat 3 times per week for 4 weeks
Other: _______________________________________\
Other: _______________________________________
Other: _______________________________________
Schedule Appt with Dr. ____________________________
Schedule Appt with Dr. ____________________________
Stroke Discharge Instructions
• Provide and review with patient/family the Acute Stroke
• Dietitian to educate on post Stroke diet and weight
Doc #85509 v1, continued on page 2 of 2
DOCS-#85509-v1-EBC_-_Acute_Stroke_Discharge_Orders_-_Alegent_Health_Administration_-_AH_(METRO).DOC
Evidence Based Care EBC Feedback Contact 717-6996 PHYSICIAN ORDERS / PROGRESS NOTES CHECK ALLERGY. DOCUMENT TYPE OF REACTION IN NURSING ASSESSMENT. MEDICATION ORDERS WILL BE DISPENSED PER HOSPITAL DRUG FORMULARY SYSTEM UNLESS SPECIFICALLY STATED AS “NDPS” OR “DAW.” PROGRESS NOTES/CONSULTATION Acute Stroke Discharge Orders Stroke Prophylaxis:
_______________________________________
_______________________________________
Other Medications:
For all appropriately selected patients with
cerebrovascular disease (eg, history of transient ischemic
attack or stroke), consider the use of antidepressants (eg,
_______________________________________
selective serotonin reuptake inhibitors) for the prevention
and treatment of depression. (Stroke 2006;37:2796-
______________________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________
______________________________________________
__________________________________________ Ordering MD/DO/NP/PA signature _________________ (Date) _____________ (Time)
DOCS-#85509-v1-EBC_-_Acute_Stroke_Discharge_Orders_-_Alegent_Health_Administration_-_AH_(METRO).DOC
¿PUEDE SER LA QUINUA PATRIMONIO CULTURAL INMATERIAL ANDINO Y DE LA HUMANIDAD? Conferencia presentada en el Congreso Internacional de la Quinoa, QUINOANDO “De los Andes a Milán y al mundo” 30 y 31 de octubre de 2013, Milán, Italia. Conferencia del programa oficial del IV Congreso Mundial de la Quinua y I Simposio Internacional de Granos Andinos, 8 al 12 de julio, Ibarra, Ecuad
T o p T w e n T y pay- f o r - D e l ay D r u g s : H o w D r u g I n D u s t r y Pay o f f s D e l ay g e n e r I c s , I n f l at e P r I c e s a n D H u r t c o n s u m e r s T oo often, consumers are forced to shoulder a heavy financial burden, or even go without needed medicine, due to the high cost of brand-name drugs. Our research indicates that one significant cause is the practic